A Phase 1, Randomized, Double-Blind, Single-Dose, Drug-Drug Interaction Study to Determine the Impact of Co-administration of QPX7728 on the Pharmacokinetics of QPX2014 in Healthy Adult Subjects
Latest Information Update: 25 Aug 2022
At a glance
- Drugs QPX 2014 (Primary) ; Xeruborbactam (Primary)
- Indications Acinetobacter infections; Bacterial infections; Pseudomonal infections
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Qpex Biopharma
Most Recent Events
- 23 Aug 2022 According to a Brii Biosciences media release, the company expects to share data from study in the fourth quarter of 2022 at a scientific conference.
- 20 Dec 2021 Status changed from recruiting to completed.
- 18 Nov 2021 Status changed from not yet recruiting to recruiting.